Skip to main content
. 2016 Apr 18;185(1):22–32. doi: 10.1111/cei.12791

Figure 3.

Figure 3

Deletion of CXCR5 decreases lymphadenopathy and splenomegaly in lupus‐prone mice. (a) Assessment of lymphadenopathy in differently aged B6/lpr and B6/lpr CXCR5–/– mice. Data indicate mean ± standard error of the mean (s.e.m.) of at least four mice per group. (b) Assessment of splenomegaly by spleen weight of differently aged B6/lpr and B6/lpr CXCR5–/– mice. Data indicate mean ± s.e.m. of at least four mice per group. (c) Representative image of spleens from 58‐week‐old B6/lpr (left) and B6/lpr CXCR5–/– (right) mice.